Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Peninsula Pharmaceuticals Inc.

Division of Johnson & Johnson

Latest From Peninsula Pharmaceuticals Inc.

Appointments: Gyroscope, Urovant, Horizon, Modus, Allied Minds And Adherium

This week's roundup includes CEO appointments by Gyroscope Therapeutics, Urovant Sciences and Nevoii Pharmaceuticals, in addition to various other high-level appointments by companies including, Horizon Pharma, Veloxis Pharmaceuticals, Modus Therapeutics and Adherium.

Appointments BioPharmaceutical

Agenovir: Using Gene Editing To Kill Viral DNA

Emerging Company Profile: Agenovir has a unique gene-editing niche – using CRISPR/Cas9 to destroy DNA in latent viral reservoirs as opposed to other companies that snip and repair errors in the genome.

StartUps and SMEs Business Strategies

In Long Venture Downturn, Flagship And Canaan Are In The Money

Two veteran life-science venture firms are pushing forward with new funds even as many of their peers can't persuade backers to open their wallets.

Business Strategies

Anthera Pharmaceuticals Inc.

The founder of Peninsula Pharmaceuticals brought investors huge multiples fast by exploiting trans-Pacific dealmaking opportunities. He's now following the same route with Anthera Pharmaceuticals in hopes of repeating his earlier success.
BioPharmaceutical North America
See All

Company Information